Literature DB >> 27298397

Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients.

France Debaugnies1, Bhavna Mahadeb2, Alina Ferster3, Nathalie Meuleman4, Laurence Rozen5, Anne Demulder5, Francis Corazza2.   

Abstract

OBJECTIVES: In this study, we compared the performances of adapted hemophagocytic lymphohistiocytosis (HLH)-2004 guidelines with those of the new diagnostic H-score to identify patients with HLH in a multicenter cohort consisting of adult and pediatric cases of suspected HLH.
METHODS: The study sample consisted of 147 cases, including 20 adults and 16 children with HLH. Two sets of biological data were evaluated: at presentation and the maximal values reached during the episode.
RESULTS: At presentation, for both children and adults, the H-score was more efficient than adapted HLH-2004 guidelines to identify HLH. The diagnostic sensitivity and specificity were respectively 100% and 80% for children and 90% and 79% for adults. However, for adults, performances became comparable between adapted HLH-2004 guidelines and H-score as patient clinical status worsened. The specificity decreased to 73% for the same sensitivity.
CONCLUSIONS: The adapted HLH-2004 guidelines seem less powerful and H-score seems to be more appropriate for children, which may be due to less significantly marked biological features. For adults, H-score performances are better when determined at presentation. The cutoff value of the H-score should be adapted depending on the target population to obtain optimal specificity. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adults; Diagnostic hematology; Hemophagocytic lymphohistiocytosis; Hemophagocytic syndrome; Pediatric

Mesh:

Year:  2016        PMID: 27298397     DOI: 10.1093/ajcp/aqw076

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  40 in total

Review 1.  Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy.

Authors:  Eric J Vick; Kruti Patel; Philippe Prouet; Mike G Martin
Journal:  Blood Adv       Date:  2017-05-09

2.  Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib.

Authors:  Scott R Goldsmith; Sana Saif Ur Rehman; Cara L Shirai; Kiran Vij; John F DiPersio
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

4.  Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.

Authors:  Michael R Ardern-Jones; Matt Stammers; Hang Tt Phan; Florina Borca; Anastasia Koutalopoulou; Ying Teo; James Batchelor; Trevor Smith; Andrew S Duncombe
Journal:  Clin Med (Lond)       Date:  2021-08-13       Impact factor: 5.410

5.  Secondary hemophagocytic lymphohistiocytosis associated with Rocky Mountain spotted fever in a toddler: A case report.

Authors:  Smitha Hosahalli Vasanna; Peter Paul C Lim; Tanya Saeeda Khan; Jignesh Dalal
Journal:  EJHaem       Date:  2022-04-05

6.  Performance of HScore in Reactive Hemophagocytic Lymphohistiocytosis.

Authors:  Neerav Khare; Sree Rekha Jinkala; Srikanta Kanungo
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-10       Impact factor: 0.900

7.  Analysis of the occurrence of hemophagocytic lymphohistiocytosis (HLH) features in patients with sepsis: a prospective study.

Authors:  Dominik Bursa; Agnieszka Bednarska; Andrzej Pihowicz; Marcin Paciorek; Andrzej Horban
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

8.  From febrile pancytopenia to hemophagocytic lymphohistiocytosis-associated organ dysfunction.

Authors:  Joseph A Carcillo; Bradley Podd; Dennis W Simon
Journal:  Intensive Care Med       Date:  2017-06-26       Impact factor: 17.440

9.  Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.

Authors:  Maria Oana Mărginean; Eniko Molnar; Mihaela Ioana Chinceşan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

10.  Chemotherapy-sparing treatment of haemophagocytic lymphohistiocytosis with intravenous immunoglobulins and corticosteroids.

Authors:  Evan C Chen; Jonathan A Stefely; Bimalangshu R Dey; Walter H Dzik
Journal:  BMJ Case Rep       Date:  2020-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.